Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 71 Records) |
| Query Trace: Lung Neoplasms and ATM[original query] |
|---|
| Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer. JAMA network open 2019 9 2 (9): e1911895. Chen Yu, Chen Gang, Li Jin, Huang Ying-Ying, Li Yi, Lin Jing, Chen Li-Zhu, Lu Jian-Ping, Wang Yu-Qi, Wang Chang-Xi, Pan Leong Kin, Xia Xue-Feng, Yi Xin, Chen Chuan-Ben, Zheng Xiong-Wei, Guo Zeng-Qing, Pan Jian- |
| Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 7 14 (11): 1924-1934. Goeman Frauke, De Nicola Francesca, Scalera Stefano, Sperati Francesca, Gallo Enzo, Ciuffreda Ludovica, Pallocca Matteo, Pizzuti Laura, Krasniqi Eriseld, Barchiesi Giacomo, Vici Patrizia, Barba Maddalena, Buglioni Simonetta, Casini Beatrice, Visca Paolo, Pescarmona Edoardo, Mazzotta Marco, De Maria Ruggero, Fanciulli Maurizio, Ciliberto Gennaro, Maugeri-Saccà Marcel |
| Polymorphisms in DNA repair genes in lung cancer patients living in a coal-mining region. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2019 Nov 28 (6): 522-528. Minina Varvara I, Bakanova Marina L, Soboleva Olga A, Ryzhkova Anastasia V, Titov Ruslan A, Savchenko Yana A, Sinitsky Maxim Yu, Voronina Elena N, Titov Victor A, Glushkov Andrey |
| Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies. International journal of cancer 2019 Oct . Qian Jie, Nie Wei, Lu Jun, Zhang Lele, Zhang Yanwei, Zhang Bo, Wang Shuyuan, Hu Minjuan, Xu Jianlin, Lou Yuqing, Dong Yu, Niu Yanjie, Yan Bo, Zhong Runbo, Zhang Wei, Chu Tianqing, Zhong Hua, Han Baoh |
| Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy. Journal of immunotherapy (Hagerstown, Md. : 1997) 2019 Sep . Pinato David J, Urus Heather, Newsom-Davis Thomas, Du Parcq Persephone, Belessiotis Katherine, Mapara Leah, Gupta Nandita, Power Danielle, Weir Justin, Wong Ching Ngar, Ratnakumaran Ragu P, Dominy Kathy, Khorashad Jamshid, Bower Ma |
| Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma Risk. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 9 15 (12): 1871-1879. Esai Selvan Myvizhi, Zauderer Marjorie G, Rudin Charles M, Jones Siân, Mukherjee Semanti, Offit Kenneth, Onel Kenan, Rennert Gad, Velculescu Victor E, Lipkin Steven M, Klein Robert J, Gümü? Zeynep |
| The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility. Translational lung cancer research 2020 7 9 (3): 646-658. Liu Mengyuan, Liu Xinyi, Suo Peisu, Gong Yuan, Qu Baolin, Peng Xiumei, Xiao Wenhua, Li Yuemin, Chen Yan, Zeng Zhen, Lu Yinying, Huang Tanxiao, Zhao Yingshen, Liu Ming, Li Lifeng, Chen Yaru, Zhou Yanqing, Liu Guifeng, Yao Jianfei, Chen Shifu, Song Le |
| Protein-altering germline mutations implicate novel genes related to lung cancer development. Nature communications 2020 May 11 (1): 2220. Ji Xuemei, Mukherjee Semanti, Landi Maria Teresa, Bosse Yohan, Joubert Philippe, Zhu Dakai, Gorlov Ivan, Xiao Xiangjun, Han Younghun, Gorlova Olga, Hung Rayjean J, Brhane Yonathan, Carreras-Torres Robert, Christiani David C, Caporaso Neil, Johansson Mattias, Liu Geoffrey, Bojesen Stig E, Le Marchand Loic, Albanes Demetrios, Bickeböller Heike, Aldrich Melinda C, Bush William S, Tardon Adonina, Rennert Gad, Chen Chu, Byun Jinyoung, Dragnev Konstantin H, Field John K, Kiemeney Lambertus Fa, Lazarus Philip, Zienolddiny Shan, Lam Stephen, Schabath Matthew B, Andrew Angeline S, Bertazzi Pier A, Pesatori Angela C, Diao Nancy, Su Li, Song Lei, Zhang Ruyang, Leighl Natasha, Johansen Jakob S, Mellemgaard Anders, Saliba Walid, Haiman Christopher, Wilkens Lynne, Fernandez-Somoano Ana, Fernandez-Tardon Guillermo, Heijden Erik H F M van der, Kim Jin Hee, Davies Michael P A, Marcus Michael W, Brunnström Hans, Manjer Jonas, Melander Olle, Muller David C, Overvad Kim, Trichopoulou Antonia, Tumino Rosario, Goodman Gary E, Cox Angela, Taylor Fiona, Woll Penella, Wichmann Erich, Muley Thomas, Risch Angela, Rosenberger Albert, Grankvist Kjell, Johansson Mikael, Shepherd Frances, Tsao Ming-Sound, Arnold Susanne M, Haura Eric B, Bolca Ciprian, Holcatova Ivana, Janout Vladimir, Kontic Milica, Lissowska Jolanta, Mukeria Anush, Ognjanovic Simona, Orlowski Tadeusz M, Scelo Ghislaine, Swiatkowska Beata, Zaridze David, Bakke Per, Skaug Vidar, Butler Lesley M, Offit Kenneth, Srinivasan Preethi, Bandlamudi Chaitanya, Hellmann Matthew D, Solit David B, Robson Mark E, Rudin Charles M, Stadler Zsofia K, Taylor Barry S, Berger Michael F, Houlston Richard, McLaughlin John, Stevens Victoria, Nickle David C, Obeidat Ma'en, Timens Wim, Artigas María Soler, Shete Sanjay, Brenner Hermann, Chanock Stephen, Brennan Paul, McKay James D, Amos Christopher |
| ATM gene polymorphisms are associated with poor prognosis of non-small cell lung cancer receiving radiation therapy. Aging 2020 4 12 (8): 7465-7479. Mou Junjun, Hu Tao, Wang Zhiwu, Chen Wei, Wang Yang, Zhang W |
| Polymorphisms and rare variants identified by next-generation sequencing confer risk for lung cancer in han Chinese population. Pathology, research and practice 2020 Feb 152873. Li Xiaoqi, Liu Jinsheng, Wang Ke, Zhou Juan, Zhang Hang, Zhang Mancang, Shi Yongyo |
| High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib. JTO clinical and research reports 2021 9 2 (7): 100191. Osoegawa Atsushi, Yamaguchi Masafumi, Nakamura Tomomi, Morinaga Ryotaro, Tanaka Kentaro, Kashiwabara Kosuke, Miura Takashi, Suetsugu Takayuki, Harada Taishi, Asoh Tatsuma, Taguchi Kenichi, Nabeshima Kazuki, Kishimoto Junji, Sakai Kazuko, Nishio Kazuto, Sugio Ken |
| The most frequent Polish ATM mutations are not susceptibility factors for tobacco-related cancers. Archives of medical science : AMS 2021 9 17 (5): 1158-1163. Podralska Marta, Dzikiewicz-Krawczyk Agnieszka, Mosor Maria, ?urawek Magdalena, I?ykowska Katarzyna, S?omski Ryszard, Rydzanicz Ma?gorzata, Gabryel Piotr, Dyszkiewicz Wojciech, Zió?kowska-Suchanek Iwo |
| Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung. Cell death & disease 2021 May 12 (5): 472. Song Zhengbo, Liu Yueping, Cheng Guoping, Chang Lianpeng, Yu Zicheng, Chen Ming, Chen Ga |
| Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G. Clinical lung cancer 2021 2 22 (3): 187-194.e1. Owonikoko Taofeek K, Redman Mary W, Byers Lauren A, Hirsch Fred R, Mack Philip C, Schwartz Lawrence H, Bradley Jeffrey D, Stinchcombe Thomas E, Leighl Natasha B, Al Baghdadi Tareq, Lara Primo, Miao Jieling, Kelly Karen, Ramalingam Suresh S, Herbst Roy S, Papadimitrakopoulou Vassiliki, Gandara David |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sönke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
| Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers. British journal of haematology 2022 8 199 (3): 371-381. Petrackova Anna, Savara Jakub, Turcsanyi Peter, Gajdos Petr, Papajik Tomas, Kriegova E |
| Rare germline deleterious variants increase susceptibility for lung cancer. Human molecular genetics 2022 Jun . Sang Jian, Zhang Tongwu, Kim Jung, Li Mengying, Pesatori Angela C, Consonni Dario, Song Lei, Liu Jia, Zhao Wei, Hoang Phuc H, Campbell Dave S, Feng James, D'Arcy Monica E, Synnott Naoise, Chen Yingxi, Wu Zeni, Zhu Bin, Yang Xiaohong R, Brown Kevin M, Choi Jiyeon, Shi Jianxin, Landi Maria Tere |
| Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 4 31 (7): 1450-1459. Mukherjee Semanti, Bandlamudi Chaitanya, Hellmann Matthew D, Kemel Yelena, Drill Esther, Rizvi Hira, Tkachuk Kaitlyn, Khurram Aliya, Walsh Michael F, Zauderer Marjorie G, Mandelker Diana, Topka Sabine, Zehir Ahmet, Srinivasan Preethi, Esai Selvan Myvizhi, Carlo Maria I, Cadoo Karen A, Latham Alicia, Hamilton Jada G, Liu Ying L, Lipkin Steven M, Belhadj Sami, Bond Gareth L, Gümü? Zeynep H, Klein Robert J, Ladanyi Marc, Solit David B, Robson Mark E, Jones David R, Kris Mark G, Vijai Joseph, Stadler Zsofia K, Amos Christopher I, Taylor Barry S, Berger Michael F, Rudin Charles M, Offit Kenne |
| Mutational status of main driver genes influences the prognosis of stage I-III lung adenocarcinoma patients underwent radical surgery. Translational cancer research 2021 Jul 10 (7): 3286-3298. Liao Hongliang, Luo Xiaoyan, Liang Yaqin, Wan Renping, Xu Me |
| PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study. BMC cancer 2022 Oct 22 (1): 1066. Kojima Kensuke, Imai Saki, Samejima Hironobu, Fujiwara Ayako, Tokunaga Toshiteru, Yoon Hyungeun, Okishio Kyoic |
| Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of KRAS-Mutated Non-Small-Cell Lung Cancer. JCO precision oncology 2022 1 5 153-162. Padda Sukhmani K, Aredo Jacqueline V, Vali Shireen, Singh Neeraj K, Vasista Sumanth M, Kumar Ansu, Neal Joel W, Abbasi Taher, Wakelee Heather |
| The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 2022 1 11 (5): 1299-1309. Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang W |
| Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC. Thoracic cancer 2023 9 . Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Minjiang Chen, Wei Zhong, Jing Zhao, Yan Xu, Mengzhao Wa |
| Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients. Translational lung cancer research 2023 7 12 (6): 1236-1244. Ju-Yoon Yoon, Jacquelyn J Roth, Chase A Rushton, Jennifer J D Morrissette, Katherine L Nathanson, Roger B Cohen, Jason N Rosenba |
| Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
| Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy. Frontiers in pharmacology 2023 3 14 1119837. Liu Jia-Si, Liu Jun-Yan, Xiao Qi, Li Xiang-Ping, Chen Juan, Liu Zhao-Qi |
| [Gene mutation profiles and clinicopathological features of patients with non-small cell lung cancer harboring KRAS G12C mutation: a single-center retrospective study]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2023 2 52 (2): 117-123. Guo L Y, Xiang C, Zhao R Y, Chen S N, Ma S J, Han Y |
| Association of Reported Candidate Monogenic Genes With Lung Cancer Risk. Clinical lung cancer 2023 2 . Rifkin Andrew S, Less Ethan M, Wei Jun, Shi Zhuqing, Zheng Siqun Lilly, Helfand Brian T, Hulick Peter J, Krantz Seth B, Xu Jianfe |
| Rate of Pathogenic Germline Variants in Patients With Lung Cancer. JCO precision oncology 2023 11 7 e2300190. Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, Elaine Chen, Sara L Bristow, Scott T Michalski, Sarah M Nielsen, Alix Lacoste, Emil Keyder, Hayan Lee, Robert L Nussbaum, Renato Martins, Edward D Espl |
| Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing. Molecular oncology 2023 10 . Zhe Yu, Zirui Zhang, Jun Liu, Xiaoying Wu, Xiaojun Fan, Jiaohui Pang, Hua Bao, Jiani Yin, Xue Wu, Yang Shao, Zhengcheng Liu, Fang L |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: